SCHEMBL12436015

SCHEMBL12436015

CCC(=O)Nc1cc(S(=O)(=O)Nc2ccc(OC)c(OC)c2)ccc1CO

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.62
SMN1; SMN2 Q16637 3/20 0.62
HTT P42858 2/20 0.62
NPSR1 Q6W5P4 2/20 0.60
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
ALOX15 P16050 1/20 0.57
MAPK1 P28482 1/20 0.57
HDAC1 Q13547 4/20 0.52
ALDH1A1 P00352 5/20 0.52
GAA P10253 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
USP2 O75604 1/20 0.51
HSP90AA1 P07900 1/20 0.51
HSP90AB1 P08238 1/20 0.51
MAPT P10636 1/20 0.51
HDAC4 P56524 3/20 0.50
HDAC3 O15379 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC2 Q92769 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12436017 0.91 SMN1; SMN2 (0.63) LMNASMN1; SMN2HTTNPSR1MEN1
SCHEMBL12435989 0.89 SMN1; SMN2 (0.58) LMNASMN1; SMN2HTTNPSR1MEN1
SCHEMBL12436008 0.86 SMN1; SMN2 (0.56) LMNASMN1; SMN2HTTNPSR1MEN1
SCHEMBL12436016 0.82 LMNA (0.51) LMNASMN1; SMN2HTTNPSR1MEN1
SCHEMBL2218687 0.80 SMN1; SMN2 (0.59) LMNASMN1; SMN2HTTNPSR1MEN1
SCHEMBL2219490 0.78 SMN1; SMN2 (0.59) LMNASMN1; SMN2HTTNPSR1MEN1
SCHEMBL12436013 0.76 KMT2A (0.58) LMNASMN1; SMN2HTTNPSR1MEN1
SCHEMBL12435992 0.74 SMN1; SMN2 (0.45) LMNASMN1; SMN2HTTNPSR1MEN1
SCHEMBL12436010 0.73 KMT2A (0.43) SMN1; SMN2HTTNPSR1MEN1KMT2A
SCHEMBL3970414 0.73 SMN1; SMN2 (0.68) LMNASMN1; SMN2NPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110178108-A1 Group of amino substituted benzoyl derivatives and their preparation and their use Institute of Medicinal Biotechnology Academy of Medical Science (CN) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178108-A1 Group of amino substituted benzoyl derivatives and their preparation and their use CUL3, APOBEC3G, BRPF3 LMNA 2812/4885SMN1; SMN2 4598/4885HTT 1248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.